The IGF-1 receptor in cancer biology

International Journal of Cancer

Volumn 107, Issue 6, 2003, Pages 873-877

  Baserga, Renato ^a   Peruzzi, Francesca ^b   Reiss, Krysztof ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell growth; Cell proliferation; IGF 1 receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY RNA; DNA DIRECTED RNA POLYMERASE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; SOMATOMEDIN C RECEPTOR;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOGENESIS; BODY SIZE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RIBOSOME; SHORT SURVEY; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; NEOPLASMS; PHOSPHOPROTEINS; RECEPTOR, IGF TYPE 1;

EID: 0242594016     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11487     Document Type: Short Survey

References (65)

1. Rosenfeld RG, Roberts CT Jr, eds. The IGF system. Totowa, NJ: Humana Press, 1999.
2. LeRoith D, Zumkeller W, Baxter R. eds. Insulin-like growth factors. Georgetown, TX: Landes Bioscience, 2002.
3. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-1 receptors. Endocrine Rev 2001;22:818-35.
4. Mauro L, Salerno ME, Morelli C, Roterberg T, Bracke ME, Surmacz E. Role of the IGF-1 receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 2002;194:108-16.
5. Baserga R, Prisco M, Yuan T. IGF-1 receptor signaling in health and disease. In: LeRoith D, Zumkeller W, Baxter R, eds. Insulin-like growth factors. Georgetown, TX: Landes Bioscience 2002:120-140.
6. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R, Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 1993;90:11217-21.
7. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 1994;14:3604-12.
8. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (Igf1r). Cell 1993;75:59-72.
9. Reiss K, Valentinis B, Tu X, Xu SQ, Baserga R. Molecular markers of IGF-1-mediated mitogenesis. Exp Cell Res 1998;242:361-72.
10. Xu SQ, Tang D, Chamberlain S, Pronks G, Masiarz FR, Kaur S, Prisco M, Zanocco-Marani T, Baserga R. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem 1998;273:20078-83.
11. He Z, Bateman A. Progranulin gene expression tegulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 1999;59:3222-9.
12. Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PHB. ETV6-NTRK3 transformation requires insulin-like growth factor I receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 2002;21:5684-95.
13. Valentinis B, Morrione A, Taylor SJ, Baserga R. Insulin-like growth factor 1 receptor signaling in transformation by src oncogenes. Mol Cell Biol 1997;17:3744-54.
14. α13 transforms mouse fibroblast cells deficient in insulin-like growth factor-I receptor. J Biol Chem 1997;272:29438-41.
15. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 1998;182:3-11.
16. Zhou-Li F, Xu S-Q, Dews M, Baserga R. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene 1997;15:961-70.
17. Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000;19:5574-81.
18. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by antisensense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 1994;54:4848-50.
19. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-1) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res 1994;54:2218-22.
20. Reiss K, D'Ambrosio C, Tu X, Tu C, Baserga R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with the by-stander effect. Clin Cancer Res 1998;4:2647-55.
21. Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. A chimeric humanized single-chain antibody against the type 1 insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effect of IGF-1. Cancer Res 2003;63:627-35.
22. Long L, Rubin R, Baserga R, Brodt P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res 1995;55:1006-9.
23. Dunn SE, Ehrlich M, Sharp NJH, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC. A dominant negative mutant of the insulin-like growth factor 1 receptor inhibits the adhesion, invasion and metastasis of breast cancer. Cancer Res 1998;58:3353-61.
24. Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky MI, Shiloh Y. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 2001;20:4029-40.
25. Liu X, Turbyville T, Fritz A, Whitesell L. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res 1998;58:5432-8.
26. Adachi Y, Lee CT, Coffee K, Yamagata N, Ohm JE, Park KH, Dikov MM, Nadaf SR, Arteaga CL, Carbone DP. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 2002;123:1191-204.
27. Shapiro DN, Jones BG, Shapiro LH, Dias P, Houghton PJ. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 1994;94:1235-42.
28. Kalebic T, Tsokos M, Helman LJ. In vivo treatment with antibody against the IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2. Cancer Res 1994;54:5531-4.
29. Lee CT, Wu S, Gabrivolich D, Chen H, Nadaf-Rahrov S, Ciernick IF, Carbone DP. Antitumor effect of an Adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res 1996;56:3038-41.
30. Scotlandi K, Avnet S, Benini S, Manara MC, Serra M, Cerisano V, Perdichizzi S, Lollini PL, DeGiovanni C. Landuzzi L, Picci P. Expression of an IGF-1 receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. Int J Cancer 2002;101:11-6.
31. Wang JY, Del Valle L, Gordon J, Rubini M, Romano G, Croul S, Peruzzi F, Khalili K, Reiss K. Activation of the IGF-1R system contributes to malignant growth of human and mouse medulloblastoma. Oncogene 2001;20:3857-68.
32. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Rev 2000;21:215-44.
33. Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan I. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci 1996;93:7263-8.
34. Conlon MA, Tomas FM, Owens PC, Wallace JC, Howarth GS, Ballard FJ. Long R/3 insulin-like growth factor I (IGF-1) infusion stimulates organ growth but reduces plasma IGF-1, IGF-1I and IGF binding protein concentrations in the guinea pig. J Endocrin 1995;146:247-53.
35. Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor 1 receptor in a pathway regulating radiation response. Proc Natl Acad Sci 2001;98:1676-81.
36. Hartwell LH. Cell division from a genetic perspective. J Cell Biol 1978;77:627-37.
37. Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M. Systematic identification of pathways that couple cell growth and division in yeast. Science 2002;297:395-400.
38. Moss T, Stefanovsky VY. Promotion and regulation of ribosomal transcription in eukaryotes by RNA polymerase I. Progr Nucl Acid Res Mol Biol 1995;50:25-66.
39. Grummt I. Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Progr Nucl Acid Res Mol Biol 1999;62:109-53.
40. Voit R, Kuhn A, Sander EE, Grummt I. Activation of mammalian ribosomal gene transcription requires phosphorylation of the nucleolar transcription factor UBF. Nucl Acids Res 1995;23:2593-9.
41. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998;42:955-76.
42. Pete G, Fuller GR, Oldham JM, Smith DR, D'Ercole AJ, Kahn CR, Lund PK. Postnatal growth responses to insulin-like growth factor 1 in insulin receptor substrate-1 mice. Endocrinology 1999;140:5478-87.
43. Bohni R, Riesco-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS-1. Cell 1999;97:865-75.
44. S6K gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998;17:6649-59.
45. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. Drosophila 6 kinase: a regulator of cell size. Science 1999;285:2126-9.
46. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat Cell Biol 1999;1:500-6.
47. Vandromme M, Rocha A, Meier R, Carnac G, Besser D, Hemmings BA, Fernandez A, Lamb NJC. Protein kinase Bβ/Akt2 plays a specific role in muscle differentiation. J Biol Chem 2001;276:8173-9.
48. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, José PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Gen 1996;12:106-9.
49. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R. Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 2000;275:25451-9.
50. Lassak A, DelValle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K. Insulin receptor substrate-I translocation to the nucleus by the human JC virus T antigen. J Biol Chem 2002;277:17231-8.
51. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R. Nuclear translocation of IRS-1 by the SV40 T antigen and the activated IGF-1 receptor. J Biol Chem 2002;277:32078-85.
52. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R. Nuclear translocation of insulin receptor substrate-1 by oncogenes and IGF-1: effect on ribosomal RNA synthesis. J Biol Chem 2002;277:44357-65.
53. Boylan JM, Gruppuso PA. Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats. Endocrinology 2002;143:4178-83.
54. Sun HZ, Tu X, Prisco M, Wu A, Casiburi I, Baserga R. IGF-1 receptor signaling and nuclear translocation of insulin receptor substrates-1 and -2. Mol Endocrinol 2003;17:472-86.
55. Wu A, Sciacca L, Baserga R. Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts. J Cell Physiol 2003;195:453-60.
56. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A, Baserga R. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 1999;274:12423-30.
57. Baserga R. Growth in size and cell DNA replication. Exp Cell Res 1984;151:1-5.
58. Lerch-Gagg A, Haque J, Li J, Ning G, Traktman P, Duncan SA. Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J Biol Chem 2002;277:45347-55.
59. II250 modulate expression of distinct subsets of mammalian genes. Proc Natl Acad Sci 2000;97:2456-61.
60. Lin CY, Tuan JA, Scalia P, Bul T, Comai L. The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF. Curr Biol 2002;12:2142-6.
61. Iben S, Tschochner H, Bler M, Hoogstraten D, Hozak P, Egly JM, Grummt I. TFIIH plays an essential role in RNA polymerase I transcription. Cell 2002;109:297-306.
62. 1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J 1999;18:1891-9.
63. Andersen JS, Lyon CE, Fox AH, Leung AKL, Lam YW, Steen H, Mann M, Lamond AI. Directed proteomic analysis of the human nucleolus. Curr Biol 2002;12:1-11.
64. Scherl A. Couté Y, Deon C, Callé A, Kinbeiter K, Sanches JC, Greco A, Hochstrasser D, Diaz JJ. Functional proteomic analysis of human nucleolus. Mol Biol Cell 2002;13:4100-9.
65. Kiely PA, Sant A, O'Connor R. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 2002;277:22581-9